Get started
Author

Sabrina Haben

Observed name: Haben, Sabrina
ORCID: 0009-0003-5852-1714
Observed ORCID: 0009-0003-5852-1714
OpenAlex ID: A5059802146
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
2023 · Sandra Thiel, Nastassja Litvin, et al. · Journal of Neurology Neurosurgery & Psychiatry · 35
PDF
Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry
2024 · Nadine Bast, Karen Dost-Kovalsky, et al. · The Lancet Regional Health - Europe · 28
Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis
2023 · Sabrina Haben, Andrea I Ciplea, et al. · Journal of Neurology Neurosurgery & Psychiatry · 26
PDF
Neonatal B-Cell Levels and Infant Health in Newborns Potentially Exposed to Anti-CD20 Monoclonal Antibodies During Pregnancy or Lactation
2024 · Carolin Schwake, Julia Steinle, et al. · Neurology Neuroimmunology & Neuroinflammation · 23
PDF
Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study
2022 · Andrea Ines Ciplea, Anna Kurzeja, et al. · Multiple Sclerosis Journal · 21
PDF
Ofatumumab-exposed breastfeeding in multiple sclerosis patients
2025 · Laura Witt, Karen Dost-Kovalsky, et al. · Multiple Sclerosis Journal · 10
PDF
Safety evaluations of offspring breastfed by mothers receiving glatiramer acetate for relapsing multiple sclerosis
2023 · Andrea I. Ciplea, Anna Kurzeja, et al. · Multiple Sclerosis and Related Disorders · 5
PDF
Glatiramer Acetate Or IFN-β Bridging Therapy in Women With Relapsing Multiple Sclerosis Planning a Pregnancy
2023 · Kerstin Hellwig, Sandra Thiel, et al. · Neurodegenerative Disease Management · 4
Impact of symptomatic multiple sclerosis therapy on pregnancy outcome
2024 · Laura Witt, Sabrina Haben, et al. · Multiple Sclerosis Journal · 3
PDF
B-cell Counts in Pregnancy Exposed Ofatumumab Neonates of Women with Multiple Sclerosis (P10-1.008)
2025 · Karen Dost-Kovalsky, Nadine Bast, et al. · Neurology · 2
Safety of breastfeeding under monoclonal antibodies in the offspring of mothers with multiple sclerosis or neuromyelitis optica spectrum disorder
2026 · Laura Witt, Natalia Friedmann, et al. · Journal of Neurology Neurosurgery & Psychiatry · 1
Anti-CD20-antibodies and Pregnancy Disease Activity in Women with Multiple Sclerosis (P10-1.004)
2025 · Nadine Bast, Karen Dost-Kovalsky, et al. · Neurology · 1
The Impact of Disease-modifying Therapy on Relapse Risk in Women with Multiple Sclerosis Undergoing Assisted Reproductive Technologies (ART) (S7.005)
2024 · Nele Range, Sabrina Haben, et al. · Neurology · 1
NEKi-S3 Guideline
2026 · Sandra Thiel, Nadine Bast, et al. · Open Science Framework
Disease Activity During Pregnancy and Postpartum in Women With Multiple Sclerosis Treated With Ocrelizumab or Rituximab Before Pregnancy
2026 · Nadine Bast, Karen Dost-Kovalsky, et al. · Neurology Neuroimmunology & Neuroinflammation
PDF
Pregnancy Outcomes and Disease Activity in Women With NMOSD and MOGAD (P8-20.006)
2026 · Nina Blum, Karen Dost-Kovalsky, et al. · Neurology
Cladribine and Pregnancy in Women with Multiple Sclerosis– A Cohort Study (P10-1.007)
2025 · Karen Dost-Kovalsky, Nadine Bast, et al. · Neurology
Pregnancy Outcomes in Multiple Sclerosis patients with or without exposure to Disease Modifying Therapies during pregnancy (N2.003)
2023 · Nadine Bast, Sandra Thiel, et al. · Neurology
Works count: 22
Citation count: 160
H-index: 6
I10-index: 6
Year
Topic
Type